Patients pursuing IV glutathione for skin-lightening or "detox" protocols should disclose all concurrent medications to the administering provider
You should speak with a healthcare provider if: Hair loss continues beyond 6 months You notice patchy hair loss , scalp irritation , or persistent redness/itching Shedding is accompanied by fatigue , brittle nails , pale skin , or easy bruising which could point to iron , B12 , or thyroid-related deficiencies Your provider may recommend: Lab testing (e.g., ferritin , thyroid panel , vitamin D , zinc ) Reviewing your nutritional intake or adjusting supplementation Modifying your semaglutide or tirzepatide dosage , if applicable Hair loss doesnt have to derail your progress
Hughes, N
Additional information An erratum to this article is available at Rights and permissions Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made
The Effect of Retatrutide Once Weekly on Cardiovascular and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
A 2 mg/ml syringe of semaglutide at typical vial sizes (2-3 ml) falls well under this limit